The FDA has approved Enflonsia (clesrovimab-cfor) for the prevention of RSV lower respiratory tract disease in neonates and ...

In a major boost for infant health, the U.S. Food and Drug Administration (FDA) has approved ENFLONSIA ™ (clesrovimab-cfor), ...

RESVIA is now authorized for use in adults aged 18–59 years with an increased risk of respiratory syncytial virus-related ...

GSK said on Friday the European Medicines Agency had accepted the drugmaker's application to expand the use of its ...

Staff who provide data to the vaccine panel have been pushed aside, according to health officials, raising doubts about the ...

Newco Elkedonia SAS has raised €11 million (US$12.7 million) in a seed round, which will fund it to take a potentially first-in-class ELK-1 inhibitor into the clinic in the treatment of refractory ...

FDA drug alerts in infectious diseases, including new drug approvals, safety warnings, recalls, and changes in indications.

Secretary of Health and Human Services Robert F. Kennedy Jr.'s appearance this week on Fox News was so chockfull of ...

Helen Chu, MD, urged doctors to find "science-based recommendations" from the American Academy of Pediatrics, the American College of Obstetricians and Gynecologists, and the American Academy of ...